Covira

Covira is a biotech company developing drugs that modulate the biological activity of the gut microbiome to prevent diseases.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Illinois City, IL, USA
  • Currency USD
  • Founded September 2018
  • Employees 9
  • Incorporation Type C-corp
  • Website covirasurgical.com

Company Summary

Covira is a biotech company developing drugs that modulate the biological activity of the gut microbiome. This microbiome-focused company is based on the work of Dr. John Alverdy, MD, a world authority on the molecular basis of post-surgical infections. Covira’s platform technology generated a lead asset CS-0003 (proprietary Pi-PEG) that modulates bacterial virulence and restores microbial communities to prevent post-surgical infection.

Team

  • Peter Farmakis
    CEO, Board Member

    Proven life sciences business and leadership successes from two Fortune 100 companies (Johnson & Johnson and Abbott Laboratories). Prior experience includes building, launching, and scaling four life science startup companies…including two in the biotech space - both biotech’s were successful exits culminating in strategic sales to larger multinational corporations.

  • Dr. John Alverdy
    Founder & Chief Scientific Officer, Board Member

    Practicing GI surgeon and professor of surgery and the executive vice-chair of surgery at the University of Chicago. Dr. Alverdy is a preeminent surgeon-scientist and globally recognized expert in surgical infection research with a focus on the molecular basis of surgical infections and the gut microbiome.

  • Jaime Contreras
    Board Member

    30-years of global leadership experience, including running a global division as an Executive Officer at Abbott Laboratories.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free